Alzheimer hope?But five minutes after being injected with etanercept – according to the film which was supplied and edited by the clinic – he greets his wife. Visibly shocked, she says he has not recognised her for years. Mr Miller then hugs her. Still:"On the surface these results are exciting but we need to treat the study with caution," she [Suzanne Sorenson, head of research at the Alzheimer's Society] said. "There are large gaps in the research, which used a small pilot group. We cannot draw conclusions until a controlled trial is carried out."
Senile link.
Link fixed, thanks what's-your-name.
Or probably not: But this newspaper has learned Dr Tobinick, 56, has previously made unfounded claims that the same drug, etanercept, could cure chronic back and neck pain.
He also has a financial interest in the success of the drug because he owns shares in its manufacturer, Amgen.
Last year Dr Tobinick was disciplined by the Medical Board of California (MBC) after he failed to provide scientific evidence that etanercept was a 'breakthrough' treatment for back pain.
He was found guilty of unprofessional conduct and placed on probation for a year. He was banned from practising for 60 days - but the order was suspended for the period of his probation.
Last year researchers conclusively proved that etanercept was not an effective treatment for back pain, although Dr Tobinick contests their methods.
In 2001, he was involved in another row when he threatened legal action against a website that challenged claims he made about his patented laser hair removal treatment.
Dr Tobinick claims he teaches at the prestigious University Of California Los Angeles (UCLA) and is a member of its clinical faculty.
But a UCLA spokesman said Dr Tobinick merely rented an office in a private building also used by the university's medical centre.
|
- jim 4-12-2008 8:25 pm
Senile link.
- alex 4-12-2008 9:54 pm [add a comment]
Link fixed, thanks what's-your-name.
- jim 4-12-2008 10:44 pm [add a comment]
Or probably not:
- jim 4-28-2008 12:26 am [add a comment]